Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 554 clinical trials
featured
ENSURE-AF

ENSURE-AF

  • 62 views
  • 25 Mar, 2021
  • 1 location
Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)

ENCHANTED2 is an international, multicenter, prospective, randomised, open, blinded end-point assessed (PROBE) trial, to assess different approaches to manage blood pressure (BP) in acute

  • 0 views
  • 25 Jan, 2021
  • 1 location
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval

The study will be a multicentre, prospective, randomized, open label, blinded endpoint (PROBE) phase 3 trial (2 arm with 1:1 randomization) in ischemic stroke patients within 4.5 hours of stroke

arterial occlusion
stroke
probe
clot
  • 129 views
  • 15 Feb, 2021
  • 35 locations
Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients With Large Vessel Occlusion

prospective, randomised, open-label, blinded endpoint (PROBE) design.

thrombolytic agent
plasminogen
probe
thrombectomy
stenosis
  • 0 views
  • 23 Jun, 2021
  • 4 locations
Trial of EXenatide in Acute Ischaemic Stroke

Phase 2, multi centre, prospective, randomised, open label, blinded end-point (PROBE) trial comparing Exenatide to Standard of Care. The sample size is 528 patients (264 in each arm).

  • 2 views
  • 23 Jan, 2021
  • 16 locations
Trial of Andexanet in ICH Patients Receiving an Oral FXa Inhibitor

Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet versus usual standard of care in patients with intracranial hemorrhage anticoagulated with a direct oral anticoagulant

  • 19 views
  • 25 Jan, 2021
  • 134 locations
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

The purpose of this study is to evaluate the objective response rate (complete response [CR]+ partial response [PR]) of the selected dose regimen in participants with metastatic or surgically unresectable urothelial cancers that harbor specific FGFR genomic alterations.

renal function
adjuvant chemotherapy
erdafitinib
measurable disease
dose regimen
  • 40 views
  • 23 Jun, 2021
  • 151 locations
The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing

The purpose of this study is to study the difference in prostate cancer between two prostate biopsy techniques, namely end-firing and side-firing. These differ in the angle at which the prostate is biopsied.

biopsy of prostate
transrectal ultrasound
  • 15 views
  • 07 Nov, 2020
  • 1 location
Outcome in Patients Treated With Intraarterial Thrombectomy - optiMAL Blood Pressure Control (OPTIMAL-BP)

Recent endovascular thrombectomy (EVT) trial have proven the effectiveness of intraarterial revascularization in patients with larger cerebral artery occlusion. The success rate of EVT is close to 80%, but only 50% of patients improve to independent functional outcome. Therefore, new treatment strategies are needed to reduce the futile revascularization. However, …

arterial occlusion
hypertension
ischemia
cerebral infarction
stroke
  • 0 views
  • 23 Jun, 2021
  • 1 location
Ultrasound Probe Pressure on the Intratendon Doppler Signal in Patellar Tendinopathy

, today and clinically speaking, merely qualitative through the observation of the explorer. The ultrasound evaluation is carried out through a probe that is placed on the patient's skin, the procedure to

  • 0 views
  • 29 Jan, 2021
  • 1 location